Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFκB signal disruption in human WISH and amnion cells

Biology of Reproduction

Volumn 73, Issue 3, 2005, Pages 527-535

  Ackerman IV, William E ^a   Zhang, Xiaolan L ^b   Rovin, Brad H ^b   Kniss, Douglas A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cytokines; Gene regulation; Parturition; Placenta; Pregnancy

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL NUCLEUS RECEPTOR; CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; PROSTAGLANDIN E2; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

AMNION CELL; ARTICLE; CELL LINE; CELL STRAIN WISH; CHILDBIRTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; COX2 GENE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LABOR; PLACENTA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN FAMILY; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMNION; CELLS, CULTURED; CHROMANS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; NF-KAPPA B; PPAR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA;

EID: 23844555532     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.039032     Document Type: Article

References (55)

1. Olson DM, Mijovic JE, Sadowsky DW. Control of human parturition. Semin Perinatol 1995; 19:52-63.
2. Kniss DA, Iams JD. Molecular effectors of human preterm parturition. In: Seifer DB, Samuels P, Kniss DA (eds.), Physiologic Basis of Gynecology and Obstetrics. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:442-455.
3. Gibb W. The role of prostaglandins in human parturition. Ann Med 1998; 30:235-241.
4. Colville-Nash PR, Gilroy DW. COX-2 and the cyclopentenone prostaglandins-a new chapter in the book of inflammation? Prostaglandins Other Lipid Mediat 2000; 62:33-43.
5. Murphy GJ, Holder JC. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000; 21: 469-474.
6. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400:378-382.
7. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391:82-86.
8. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391:79-82.
9. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab 2002; 87:4667-4672.
10. 2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem 2004; 279:22057-22065.
11. 2. Proc Natl Acad Sci U S A 1999; 96:4668-4673.
12. Baeuerle PA. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 1998; 95:729-731.
13. Poligone B, Baldwin AS. Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem 2001; 276:38658-38664.
14. Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000; 6:561-565.
15. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999; 181:359-366.
16. Yan X, Wu XC, Sun M, Tsang BK, Gibb W. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. Biol Reprod 2002; 66:1667-1671.
17. Ackerman WE IV, Rovin BH, Kniss DA. Epidermal growth factor and interleukin-1beta use divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol Reprod 2004; 71:2079-2086.
18. Kniss DA. Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest 1999; 6:285-292.
19. 2 attenuates the development of acute and chronic inflammation. Mol Pharmacol 2002; 61:997-1007.
20. Dunn-Albanese LR, Ackerman WE 4th, Xie Y, Iams JD, Kniss DA. Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am J Obstet Gynecol 2004; 190:809-816.
21. Okita JR, Sagawa N, Casey ML, Snyder JM. A comparison of human amnion tissue and amnion cells in primary culture by morphological and biochemical criteria. In Vitro 1983; 19:117-126.
22. Kniss DA, Rovin B, Fertel RH, Zimmerman PD. Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells. Placenta 2001; 22:80-89.
23. Zhang X, Lu L, Dixon C, Wilmer W, Song H, Chen X, Rovin BH. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14- prostaglandin J2 in human mesangial cells. Kidney Int 2004; 65:798-810.
24. Perkins DJ, Kniss DA. Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs. Prostaglandins 1997; 54:727-743.
25. 2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism. Biochem Biophys Res Commun 2003; 302:415-420.
26. 2 in activated human astrocytes, but not in human brain macrophages. J Immunol 2002; 168:4747-4755.
27. 2-induced apoptosis in amnion-like WISH cells. Prostaglandins Other Lipid Mediat 2001; 66:265-282.
28. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 2000; 97:4844-4849.
29. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nat Med 2001; 7:48-52.
30. Fukushima M. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids 1992; 47:1-12.
31. Atsmon J, Sweetman BJ, Baertschi SW, Harris TM, Roberts LJ. Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. Biochemistry 1990; 29: 3760-3765.
32. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995; 83:803-812.
33. Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P, Bosca L. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12, 14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 2000; 20:1692-1698.
34. Mullally JE, Moos PJ, Edes K, Fitzpatrick FA. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J Biol Chem 2001; 276:30366-30373.
35. Verbitski SM, Mullally JE, Fitzpatrick FA, Ireland CM. Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J Med Chem 2004; 47:2062-2070.
36. Tazawa R, Xu XM, Wu KK, Wang LH. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin II synthase-2 gene. Biochem Biophys Res Commun 1994; 203:190-199.
37. Hayflick L. The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res 1961; 23:14-20.
38. Kniss DA, Zimmerman PD, Fertel RH, Iams JD. Proinflammatory cytokines interact synergistically with epidermal growth factor to stimulate PGE2 production in amnion-derived cells. Prostaglandins 1992; 44:237-244.
39. Bry K. Epidermal growth factor and transforming growth factor-alpha enhance the interleukin-1- and tumor necrosis factor-stimulated prostaglandin E2 production and the interleukin-1 specific binding on amnion cells. Prostaglandins Leukot Essent Fatty Acids 1993; 49:923-928.
40. Hansen WR, Drew A, Helsby N, Keelan JA, Sato TA, Mitchell MD. Regulation of cytosolic phospholipase A2 expression by cytokines in human amnion cells. Placenta 1999; 20:303-308.
41. Kniss DA, Xie Y, Li Y, Kumar S, Linton EA, Cohen P, Fan-Havard P, Redman CW, Sargent IL. ED(27) trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta 2002; 23:32-43.
42. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001; 169:453-459.
43. Lindstrom TM, Bennett PR. 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IL-1beta-induced NF-kappaB in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab 2005; 90:3534-3543.
44. Perez-Sala D, Cernuda-Morollon E, Canada FJ. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-delta(12,14)-prostaglandin J2. J Biol Chem 2003; 278:51251-51260.
45. 2. J Biol Chem 1999; 274:17042-17048.
46. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000; 106:189-197.
47. Meade EA, McIntyre TM, Zimmerman GA, Prescott SM. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999; 274:8328-8334.
48. Subbaramaiah K, Lin DT, Hart JC, Dannenberg AJ. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem 2001; 276: 12440-12448.
49. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270:12953-12956.
50. Mitchell MD, Kraemer DL, Strickland DM. The human placenta: a major source of prostaglandin D2. Prostaglandins Leukot Med 1982; 8:383-387.
51. Berryman GK, Strickland DM, Hankins GD, Mitchell MD. Amniotic fluid prostaglandin D2 in spontaneous and augmented labor. Life Sci 1987; 41:1611-1614.
52. Marvin KW, Eykholt RL, Keelan JA, Sato TA, Mitchell MD. The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 2000; 21:436-440.
53. Glass CK. Potential roles of the peroxisome proliferator-activated receptor-γ in macrophage biology and atherosclerosis. J Endocrinol 2001; 169:461-464.
54. Tzameli I, Fang H, Oilero M, Shi H, Hamm JK, Kievitt P, Hollenberg AN, Flier JS. Regulated production of a peroxisome proliferator-activated receptor-g ligand during an early period of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem 2004; 279:36093-36102.
55. Waite LL, Louie RE, Taylor RN. Circulating activators of PPARs are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 2004; 90:620-626.